Related Experiment Video
Updated: Aug 14, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Cerebral Microhemorrhages: Significance, Associations, Diagnosis, and Treatment
Eric Jouvent1, Laurent Puy1, Hugues Chabriat2
1Univ Paris Diderot, UMR-S 1161 INSERM and DHU NeuroVasc Sorbonne Paris Cité and AP-HP, Lariboisière Hosp, Department of Neurology, 2 rue Ambroise Paré, 75010, Paris, France.
Insights
Cerebral microhemorrhages (CMs) are increasingly detected with brain MRI and help assess hemorrhagic versus ischemic risks. Integrating CM data into personalized medicine will improve patient management for cerebrovascular diseases.
Area of Science:
- Neurology
- Radiology
- Vascular Medicine
Background:
- Cerebrovascular pathologies present both ischemic and hemorrhagic risks, particularly in aging populations.
- Brain magnetic resonance imaging (MRI) is a primary tool for evaluating cerebrovascular diseases.
- Cerebral microhemorrhages (CMs) are small foci of signal loss on MRI, initially considered imaging artifacts.
Purpose of the Study:
- To review the evolving understanding of cerebral microhemorrhages (CMs).
- To highlight the role of CMs in estimating hemorrhagic versus ischemic risks.
- To discuss the integration of CMs into personalized patient management for cerebrovascular diseases.
Main Methods:
- Review of research studies on cerebral microhemorrhages (CMs) over the past 20 years.
- Analysis of the clinical significance of CMs detected via brain MRI.
- Exploration of the potential for CMs in personalized medicine.
Main Results:
- CMs are now recognized as indicators of small vessel rupture, not just imaging artifacts.
- CMs provide valuable information for assessing the balance between hemorrhagic and ischemic risks.
- The number and location of CMs offer crucial data for clinical decision-making.
Conclusions:
- Cerebral microhemorrhages (CMs) are significant imaging biomarkers in cerebrovascular diseases.
- Understanding CMs is essential for personalized treatment strategies.
- Integrating CM assessment into patient management is critical for future clinical practice.
Opinion Statement:
Cerebrovascular pathologies expose patients to both ischemic and hemorrhagic risks. Given the progressive aging of populations, more and more patients will experience both types of events during their lifetime. The generalization of brain magnetic resonance imaging as a first-line imaging modality for evaluating patients with cerebrovascular diseases has led to the need to manage new types of imaging information about the cerebral tissue, such as the presence, location, and number of cerebral microhemorrhages (CMs). Originally, CMs were thought to be merely spatially localized distortions of the image, mostly secondary to foci of iron deposition within the brain parenchyma. During the past 20 years, however, innumerable research studies have demonstrated that these small foci of signal loss, presumably related to a circumscribed rupture of small vessels, may be used to better estimate the balance between hemorrhagic and ischemic risks. We are now entering the era of personalized medicine, in which treatment decisions are adjusted for each patient according to various genetic, biological, or imaging data. Therefore, integrating CMs into patient management at the individual level will be crucial in the future. This review aims to deliver some clues to interpret the impact of CMs on our clinical decisions.
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology

